Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 3/2018

01-07-2018 | Original Article

Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score

Authors: Gustavo N. Araujo, Fernando Pivatto Junior, Bruno Fuhr, Elvis P. Cassol, Guilherme P. Machado, Felipe H. Valle, Luiz C. Bergoli, Rodrigo V. Wainstein, Carisi A. Polanczyk, Marco V. Wainstein

Published in: Cardiovascular Intervention and Therapeutics | Issue 3/2018

Login to get access

Abstract

Contrast-induced acute kidney injury (CI-AKI) is a common event after percutaneous coronary intervention (PCI). Presently, the main strategy to avoid CI-AKI lies in saline hydration, since to date none pharmacologic prophylaxis proved beneficial. Our aim was to determine if a low complexity mortality risk model is able to predict CI-AKI in patients undergoing PCI after ST elevation myocardial infarction (STEMI). We have included patients with STEMI submitted to primary PCI in a tertiary hospital. The definition of CI-AKI was a raise of 0.3 mg/dL or 50% in post procedure (24–72 h) serum creatinine compared to baseline. Age, glomerular filtration and ejection fraction were used to calculate ACEF-MDRD score. We have included 347 patients with mean age of 60 years. In univariate analysis, age, diabetes, previous ASA use, Killip 3 or 4 at admission, ACEF-MDRD and Mehran scores were predictors of CI-AKI. After multivariate adjustment, only ACEF-MDRD score and diabetes remained CI-AKI predictors. Areas under the ROC curve of ACEF-MDRD and Mehran scores were 0.733 (0.68–0.78) and 0.649 (0.59–0.70), respectively. When we compared both scores with DeLong test ACEF-MDRDs AUC was greater than Mehran’s (P = 0.03). An ACEF-MDRD score of 2.33 or lower has a negative predictive value of 92.6% for development of CI-AKI. ACEF-MDRD score is a user-friendly tool that has an excellent CI-AKI predictive accuracy in patients undergoing primary percutaneous coronary intervention. Moreover, a low ACEF-MDRD score has a very good negative predictive value for CI-AKI, which makes this complication unlikely in patients with an ACEF-MDRD score of <2.33.
Literature
1.
go back to reference Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.CrossRefPubMed Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.CrossRefPubMed
2.
go back to reference James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6:37–43.CrossRefPubMed James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6:37–43.CrossRefPubMed
3.
go back to reference Moscucci M. Contrast-induced acute kidney injury: the continuous quest for pharmacological prevention. Circ Cardiovasc Interv. 2012;5:741–3.CrossRefPubMed Moscucci M. Contrast-induced acute kidney injury: the continuous quest for pharmacological prevention. Circ Cardiovasc Interv. 2012;5:741–3.CrossRefPubMed
4.
go back to reference Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–9.PubMed Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–9.PubMed
5.
go back to reference Abellás-Sequeiros RA, Raposeiras-Roubin S, Abu-Assi E, González-Salvado V, Iglesias-Álvarez D, Redondo-Diéguez A, et al. Mehran contrast nephropathy risk score: is it still useful 10 years later? J Cardiol. 2016;67:262–7.CrossRefPubMed Abellás-Sequeiros RA, Raposeiras-Roubin S, Abu-Assi E, González-Salvado V, Iglesias-Álvarez D, Redondo-Diéguez A, et al. Mehran contrast nephropathy risk score: is it still useful 10 years later? J Cardiol. 2016;67:262–7.CrossRefPubMed
6.
go back to reference Wi J, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, et al. Prediction of contrast-induced nephropathy with persistent renal dysfunction and adverse long-term outcomes in patients with acute myocardial infarction using the Mehran risk score. Clin Cardiol. 2013;36:46–53.CrossRefPubMed Wi J, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, et al. Prediction of contrast-induced nephropathy with persistent renal dysfunction and adverse long-term outcomes in patients with acute myocardial infarction using the Mehran risk score. Clin Cardiol. 2013;36:46–53.CrossRefPubMed
7.
go back to reference Araujo GN, Wainstein MV, McCabe JM, Huang PH, Govindarajulu US, Resnic FS. Comparison of two risk models in predicting the incidence of contrast-induced nephropathy after percutaneous coronary intervention. J Interv Cardiol. 2016;29:447–53.CrossRefPubMed Araujo GN, Wainstein MV, McCabe JM, Huang PH, Govindarajulu US, Resnic FS. Comparison of two risk models in predicting the incidence of contrast-induced nephropathy after percutaneous coronary intervention. J Interv Cardiol. 2016;29:447–53.CrossRefPubMed
8.
go back to reference Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119:3053–61.CrossRefPubMed Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119:3053–61.CrossRefPubMed
9.
go back to reference Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Jeong MH, et al. Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction. Am J Cardiol. 2015;115:1167–73.CrossRefPubMed Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Jeong MH, et al. Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction. Am J Cardiol. 2015;115:1167–73.CrossRefPubMed
10.
go back to reference Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Goedhart D, Morel MA, et al. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‘All-Comers’ LEADERS trial. Circ Cardiovasc Interv. 2011;4:47–56.CrossRefPubMed Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Goedhart D, Morel MA, et al. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‘All-Comers’ LEADERS trial. Circ Cardiovasc Interv. 2011;4:47–56.CrossRefPubMed
11.
go back to reference Capodanno D, Marcantoni C, Ministeri M, Dipasqua F, Zanoli L, Rastelli S, et al. Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the age, creatinine, ejection fraction (ACEF) score in patients undergoing percutaneous coronary intervention. Int J Cardiol. 2013;168:396–402.CrossRefPubMed Capodanno D, Marcantoni C, Ministeri M, Dipasqua F, Zanoli L, Rastelli S, et al. Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the age, creatinine, ejection fraction (ACEF) score in patients undergoing percutaneous coronary intervention. Int J Cardiol. 2013;168:396–402.CrossRefPubMed
12.
go back to reference Lakhal K, Ehrmann S, Chaari A, Laissy JP, Régnier B, Wolff M, et al. Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care. 2011;26:593–9.CrossRefPubMed Lakhal K, Ehrmann S, Chaari A, Laissy JP, Régnier B, Wolff M, et al. Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care. 2011;26:593–9.CrossRefPubMed
13.
go back to reference Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial. Circulation. 1987;75:817–29.CrossRefPubMed Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial. Circulation. 1987;75:817–29.CrossRefPubMed
14.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.CrossRefPubMed
15.
go back to reference Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27:4263–72.CrossRefPubMedPubMedCentral Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27:4263–72.CrossRefPubMedPubMedCentral
16.
go back to reference Blanc B, Finch CA, Halberg L, Herbert V, Lawkowicz W, Larysse M, et al. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37. Blanc B, Finch CA, Halberg L, Herbert V, Lawkowicz W, Larysse M, et al. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37.
17.
go back to reference Brown JR, MacKenzie TA, Maddox TM, Fly J, Tsai TT, Plomondon ME, et al. Acute kidney injury risk prediction in patients undergoing coronary angiography in a National Veterans Health Administration Cohort with external validation. J Am Heart Assoc. 2015;4:1–15.CrossRef Brown JR, MacKenzie TA, Maddox TM, Fly J, Tsai TT, Plomondon ME, et al. Acute kidney injury risk prediction in patients undergoing coronary angiography in a National Veterans Health Administration Cohort with external validation. J Am Heart Assoc. 2015;4:1–15.CrossRef
18.
go back to reference Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515–9.CrossRefPubMed Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515–9.CrossRefPubMed
19.
go back to reference Gurm HS, Seth M, Kooiman J, Share D. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2013;61:2242–8.CrossRefPubMed Gurm HS, Seth M, Kooiman J, Share D. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2013;61:2242–8.CrossRefPubMed
20.
go back to reference Tziakas D, Chalikias G, Stakos D, Apostolakis S, Adina T, Kikas P, et al. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. Int J Cardiol. 2013;163:46–55.CrossRefPubMed Tziakas D, Chalikias G, Stakos D, Apostolakis S, Adina T, Kikas P, et al. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. Int J Cardiol. 2013;163:46–55.CrossRefPubMed
21.
go back to reference Ivanes F, Isorni MA, Halimi JM, Fauchier L, Saint Etienne C, Babuty D, et al. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty. Arch Cardiovasc Dis. 2014;107:424–32.CrossRefPubMed Ivanes F, Isorni MA, Halimi JM, Fauchier L, Saint Etienne C, Babuty D, et al. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty. Arch Cardiovasc Dis. 2014;107:424–32.CrossRefPubMed
22.
go back to reference Liu YH, Liu Y, Tan N, Chen JY, Chen J, Chen SH, et al. Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention. Int Urol Nephrol. 2014;46:417–26.CrossRefPubMed Liu YH, Liu Y, Tan N, Chen JY, Chen J, Chen SH, et al. Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention. Int Urol Nephrol. 2014;46:417–26.CrossRefPubMed
23.
go back to reference Elbasan Z, Sahin DY, Gür M, Kuloglu O, Kivrak A, Icen YK, et al. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology. 2014;65:37–42.CrossRefPubMed Elbasan Z, Sahin DY, Gür M, Kuloglu O, Kivrak A, Icen YK, et al. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology. 2014;65:37–42.CrossRefPubMed
24.
go back to reference Capodanno D, Ministeri M, Dipasqua F, Dalessandro V, Cumbo S, Gargiulo G, et al. Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization. J Cardiovasc Med (Hagerstown). 2016;17:524–9.CrossRef Capodanno D, Ministeri M, Dipasqua F, Dalessandro V, Cumbo S, Gargiulo G, et al. Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization. J Cardiovasc Med (Hagerstown). 2016;17:524–9.CrossRef
25.
go back to reference Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Ferrante G, Acquaviva R, et al. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2016;210:4–9.CrossRefPubMed Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Ferrante G, Acquaviva R, et al. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2016;210:4–9.CrossRefPubMed
26.
go back to reference Liu Y, Zhou Y, He P, Yu D, Li L. Comparison of different risk scores for predicting contrast induced nephropathy and outcomes after primary percutaneous coronary intervention in patients with ST elevation myocardial infarction. Am J Cardiol. 2016;117:1896–903.CrossRefPubMed Liu Y, Zhou Y, He P, Yu D, Li L. Comparison of different risk scores for predicting contrast induced nephropathy and outcomes after primary percutaneous coronary intervention in patients with ST elevation myocardial infarction. Am J Cardiol. 2016;117:1896–903.CrossRefPubMed
27.
go back to reference Silvain J, Collet JP, Montalescot G. Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention? Eur Heart J. 2014;35:1504–6.CrossRefPubMed Silvain J, Collet JP, Montalescot G. Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention? Eur Heart J. 2014;35:1504–6.CrossRefPubMed
28.
go back to reference Rudnick M, Feldman H. Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol. 2008;3:263–72.CrossRefPubMed Rudnick M, Feldman H. Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol. 2008;3:263–72.CrossRefPubMed
29.
go back to reference Sato A, Hoshi T, Kakefuda Y, Harunari T, Watabe H, Hiraya D, et al. Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. J Cardiol. 2015;66:417–22.CrossRefPubMed Sato A, Hoshi T, Kakefuda Y, Harunari T, Watabe H, Hiraya D, et al. Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. J Cardiol. 2015;66:417–22.CrossRefPubMed
30.
go back to reference Sgura FA, Bertelli L, Monopoli D, Leuzzi C, Guerri E, Spartà I, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010;3:491–8.CrossRefPubMed Sgura FA, Bertelli L, Monopoli D, Leuzzi C, Guerri E, Spartà I, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010;3:491–8.CrossRefPubMed
31.
go back to reference Ando G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G. Age, glomerular filtration rate, ejection fraction, and the ACEF-MDRD score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2013;82:878–85.CrossRefPubMed Ando G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G. Age, glomerular filtration rate, ejection fraction, and the ACEF-MDRD score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2013;82:878–85.CrossRefPubMed
32.
go back to reference Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. ESC/EACTS myocardial revascularization guidelines 2014. Eur Heart J. 2014;35:3235–6.CrossRefPubMed Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. ESC/EACTS myocardial revascularization guidelines 2014. Eur Heart J. 2014;35:3235–6.CrossRefPubMed
Metadata
Title
Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score
Authors
Gustavo N. Araujo
Fernando Pivatto Junior
Bruno Fuhr
Elvis P. Cassol
Guilherme P. Machado
Felipe H. Valle
Luiz C. Bergoli
Rodrigo V. Wainstein
Carisi A. Polanczyk
Marco V. Wainstein
Publication date
01-07-2018
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 3/2018
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-017-0472-y

Other articles of this Issue 3/2018

Cardiovascular Intervention and Therapeutics 3/2018 Go to the issue